cell sources for cardiac tissue engineering: in-vivo approach
TRANSCRIPT
-
7/25/2019 Cell Sources for Cardiac Tissue Engineering: In-vivo approach
1/21
Cardiac Tissue Engineering: Proposal for an Improved In Vivo Approach
December 12, 2013
Daniel Houck
Michael Warren
Andrew Vienot
Introduction
In the development o 3D ti!!ue en"ineerin" !olution!, creation o cardiac ti!!ue o
!i"niicant volume will be re#uired$ %hi! will re#uire development! !peciicall& in the area! o
an"io"ene!i! and cell !timulation$ Without an"io"ene!i!, cardiac ti!!ue con!truction i! limited to
material! with cell thickne!! at or ewer than three cell!, ater which due to a lack o diu!ion
cell! will become necrotic '1($ )urrentl&, method! o va!culari*ation ma& be broken into two
main cate"orie!+ intrin!ic va!culari*ation development o blood ve!!el! in!ide the bod&-, and
e.trin!ic '3($ /econdl&, due to ti"htl& interconnected nature o cardiac cell! it i! nece!!ar& to
!timulate them in order or them to orm into the proper !hape$ In thi! area, the current method!
are electrical !timulation and mechanical !timulation 'DDD($ %he lon"er the cell i! the arther it
can contract and the ali"nment o the cell! indicate! how or"ani*ed the contraction! will be
'DDD($ ative heart cell! are "enerall& well ali"ned and elon"ated$ While there are multiple
dierin" avenue! bein" pur!ued in both, no !tudie! are bein" perormed at the uncture o the!e
two ield! the creation o cell con!truct! which are va!culari*ed to improve ho!t acceptance and
1
-
7/25/2019 Cell Sources for Cardiac Tissue Engineering: In-vivo approach
2/21
are al!o electromechanicall& optimi*ed in order to improve the contractile re!pon!e and
ultimatel& the eection raction$
Necessity
A! o 2010, heart di!ea!e, in mo!t ca!e! m&ocardial inarction, i! con!i!tentl& the top
cau!e o death in the nited /tate!$ Appro.imatel& 245 o reported death! 2$46 million- were
due to di!ea!e! o the heart, and cardiova!cular di!ea!e co!t! the nited /tate! 272$8 billion
dollar! ever& &ear$ Alarmin"l&, proection! have the!e co!t! increa!in" over 2005 to 919 billion
dollar! b& 2030 '4($ %he advent o lon" term and co!t eective !olution! will become ever more
nece!!ar&$
Physiological effects of Cardiac Disease
%he e.tent o dama"e to the cardiova!cular !&!tem varie! with man& actor!, !uch a!
duration o cardiac incident, ti!!ue re!pon!e, and prior ti!!ue condition$ In order to develop
applicable treatment!, the mechani!m o cellular death and the con!e#uence! mu!t be di!cu!!ed
in detail$ %he mo!t widel& known t&pe o )VD i! acute m&ocardial inarction!, al!o known a!
heart attack!, re!ultin" rom prolon"ed i!chemia within the m&ocardial ti!!ue7-$ %he inarction
occur! re#uentl& due to pla#ue buildup within the coronar& arter&, preventin" down!tream blood
low$ %he patholo"ical mechani!m o m&ocardial necro!i! ollow! throu"h the i!chemic ca!cade
activated in re!pon!e to the reduction o blood low to the aected ti!!ue$ %he lack o o.&"en
prompt! multiple !ide+mechani!m! includin" anaerobic "l&col&!i!, h&drol&*ation b& l&!o!omal
activation, and apopto!i!'7-+9-($ nder anaerobic condition!, m&ocardioc&te! be"in to
breakdown hi"h+ener"& pho!phate! !uch a! adeno!ine tripho!phate A%:- into adeno!ine
dipho!phate! AD:-$ 3
2
-
7/25/2019 Cell Sources for Cardiac Tissue Engineering: In-vivo approach
3/21
;i"ure 1 :atho"ene!i! o M&ocardial )ell Death
%he breakdown proce!! continue! until the pho!phate chain i! removed and adeno!ine i!
relea!ed$ %he reduction o A%: and AD: eect! intracellular proce!!e! !peciicall& !huttin"
down the !odium and calcium pump!
-
7/25/2019 Cell Sources for Cardiac Tissue Engineering: In-vivo approach
4/21
intracellular protein! bindin" within m&ocardioc&te! have brou"ht attention to the po!!ibilit& o
blockin" the!e protein! to enhance ti!!ue !urvival 13-$
%he ran"e o cardiac ti!!ue de!truction varie! primaril& on the duration o i!chemic
condition!$ %&picall& minor inliction! to the cardiac ti!!ue occur ater 18+20 minute!= in
contra!t, maor ti!!ue death occur! ater three to our hour! 14-$ In other i!chemic aliction!,
!uch a! cerebral i!chemia, the e.tent o ti!!ue death i! va!tl& lower than that o cardiac i!chemia
14-$ With current technolo"& it i! po!!ible to retain normal unction ater a cardiova!cular event,
however ri!k! or additional inarction! and cardiac ailure ri!e! !i"niicantl&$ %hereore the
e.tent o ti!!ue death i! likel& to determine the e.tent o treatment$ In ca!e o complete cardiac
ailure, tran!plantation i! the onl& known procedure to prevent death$ With donor or"an !horta"e!
pla"uin" ho!pital! worldwide, new approache! and procedure! are needed in order to combat
)VD$
Disease Treatment
)urrentl&, treatment option! are de!i"ned with the "oal o a- re!torin" blood low, and b-
decrea!in" the amount and eect o the !car ti!!ue '6($
%wo main method! which re!tore blood low are thrombol&!i! and an"iopla!t&$ In
thrombol&!i!, u!in" either mechanical or chemical method!, the blocka"e i! broken down or
removed, re!torin" blood low$ In an"iopla!t&, commonl& known a! balloon, a mechanical device
i! u!ed to e.pand a collap!ed blood ve!!el, once a"ain re!torin" blood low '9($ Method! !uch a!
the!e decrea!e the amount o dama"e done to the m&ocardium, con!e#uentl& lowerin" the
amount o ventricular remodelin" and !car ti!!ue that develop! '
-
7/25/2019 Cell Sources for Cardiac Tissue Engineering: In-vivo approach
5/21
%he current treatment )aptopril i! the onl& dru" aimin" to inhibit the ormation o !car
ti!!ue, and doe! !o b& inhibitin" an"ioten!in II+ which aid in ibrobla!t and colla"en ormation
'10($ However, the eicac& o thi! dru" i! !till conte!ted '10($
%he!e method! which are approved b& the ;DA, althou"h valuable, do not provide
mechani!m! to rever!e the ne"ative eect! o the inarction+ namel& !car ti!!ue development and
ventricular remodelin"$ )on!e#uentl&, the onl& eective treatment option or patient! with late+
!ta"e heart ailure i! heart tran!plantation '11($ %hi! ha! numerou! i!!ue! includin" the need or
immune+!uppre!!ant!, ailure o the "rat, and i! urther limited b& the low number o donor!
'12($ %he !hortcomin"! o the!e therap& method! provide opportunitie! or ti!!ue en"ineer! to
provide meanin"ul product! with which to improve #ualit& o lie and in a !econdar& manner
provide model! with which to te!t urther product! de!tined or cardiac u!e!$
>ptimization in Tissue Engineering
Electrical timulation
!echanical timulation
%he inherent d&namic! o the heart make mechanical !timulation a clear actor in cardiac
cell "rowth$ %he con!tant mechanical !tre!! applied to natural heart ti!!ue ha! been linked to
man& !i"nal! or "ene !timulation and protein !&nthe!i!$ %here i! evidence that mechanical
!timulation cau!e! !everal "rowth actor! to be created and relea!ed in cardiac ti!!ue$ %he!e
"rowth actor! !i"niicantl& aect the !tructure and unctionalit& o the cardiac ti!!ue$ ;or
en"ineered cardiac ti!!ue, two maor t&pe! o mechanical !timulation have been !tudied applied
pre!!ure and !tretch$ ?oth t&pe! o mechanical !timulation have been !hown to improve the
ormation and behavior o en"ineered cardiac ti!!ue4,2$
5
-
7/25/2019 Cell Sources for Cardiac Tissue Engineering: In-vivo approach
6/21
Applied Pressure
Applied pre!!ure !timulation can be evenl& applied to en"ineered cardiac ti!!ue b& a
bioreactor containin" a pi!ton device$ /tudie! have been done comparin" the cellular re!pon!e!
to con!tant compre!!ion, intermittent compre!!ion, and no compre!!ion$ ;i"ure 4 !how! ima"e!
comparin" cardiom&oc&te! that have been !timulated with each t&pe o compre!!ion or our
da&!$ )ontinuou! compre!!ion cau!e! the cardiac cell! to become round$ ?ecau!e the elon"ated
!hape o cardiac cell! i! related to the pul!ation o the ti!!ue, the round !hape i! indicative o
poor cardiac ti!!ue behavior$ %he cell! the e.perienced intermittent compre!!ion became
elon"ated and looked !imilar to the control cell! that received no !timulation$ %he!e cell! are
much more likel& to behave like natural cardiac ti!!ue$
Applied tretching
the eect o mechanical !tretch on en"ineered cardiac ti!!ue i! the other widel& !tudied
t&pe o mechanical !timulation$ It i! believed that the natural beatin" o the heart induce!
!tretchin" which tri""er! the "rowth o cardiom&oc&te!2
$ %i!!ue en"ineer! attempt to mimic thi!
!timulation in cultured cell! to create unctionin" cardiac ti!!ue$ ;i"ure 9 !how! the de!i"n o a
bioreactor u!ed to appl& !tretchin" !timulation to cardiac ti!!ue$ %he reactor wa! u!ed in an
e.periment that wa! ocu!ed on determinin" the eect o chronic !tretch on cardiac ti!!ue$ In the
e.periment, cell! were cultured or our da&!, and then e.po!ed to unidirectional !tretch in thi!
device or a total o !i. da&!$ %he amplitude o the !tretch wa! varied rom 15 o the ori"inal
area to 205 o the area to determine the optimum$ %he eect! o the !tretch on the en"ineered
cardiac ti!!ue were monitored and the re!ult! are di!pla&ed in i"ure! < and 10$ ;i"ure < !how!
an ima"e o a Hemato.&lin+eo!in !tained !ection o the both the !tretched and un+!tretched
cardiom&oc&te!$ %he i"ure !how! that the !tretched cardiom&oc&te! have "rown noticeabl&
6
-
7/25/2019 Cell Sources for Cardiac Tissue Engineering: In-vivo approach
7/21
lon"er and more or"ani*ed$ %hi! re!ult i! conirmed b& i"ure 10 which "raphicall& !how! the
width dierence between !tretched and un+!tretched cardiac cell!$ %he hi"her percenta"e o un+
!tretched cell! in the low width ran"e indicate that the !tretchin" induced the cell! to elon"ate
like natural cardiac ti!!ue$ %hi! improved
!tructure i! likel& to po!itivel& aect the cardiac
behavior o the cell!$ %he chronic !tretch wa!
al!o reported to have an eect on the @ADA
and protein cell ratio2$ %hi! i! "enerall&
re"arded to improve the cardiac behavior o
cell!$ %he combined re!ult! o thi! e.periment
indicate that the behavior o cardiom&oc&te!
cultured in vitro are more like native ti!!ue when
the& are applied to chronic !tretch$ /tretchin"
mechanical !timulation appear! to po!itivel&
contribute to the contractile unction o en"ineered
cardiac ti!!ue$
7
Figure 9:Image comparing un-stretched (left) and stretched (right) cardiac tissue2
Figure 8:Bioreactor used for strech of
cardiac tissue2
Figure 10:Effect of stretch on cell size2
-
7/25/2019 Cell Sources for Cardiac Tissue Engineering: In-vivo approach
8/21
Angiogenesis
An"io"ene!i! i! the proce!! b& which new microcirculator& ve!!el! "row and !prout rom
pre+e.i!tin" ve!!el! '2($ %hi! i! dier! rom both embr&onic and po!t+natal va!culo"ene!i! in
which an"io"enic ve!!el! are created either de novo in the ca!e o embr&onic, or b& circulatin"
an"iobla!t!$ Much o the re!earch into an"io"ene!i! ha! been perormed b& re!earcher! in cancer
medicine, a! a ke& i!!ue with tumor cell! i! their abilit& to promote an"io"ene!i!, thu! allowin"
them to "row pa!t diu!ion limitation! '22($ Bectivel&, in the proce!! o an"io"ene!i!
endothelial cell! prolierate under the control o "rowth actor!, mechanical, and chemical
environment!, and !prout new ve!!el! rom pre+e.i!tin" ve!!el! '2($ Ater thi!, the va!cular
network i! !tabili*ed b& !mooth mu!cle cell!$ Multiple va!cular endothelial "rowth actor
i!oorm! VBC;- are nece!!ar& durin" the proce!! alon" with dierin" placental, and ibrobla!t
"rowth actor! '2($ Mana"ement o the!e var&in" ph&!iolo"ical actor! "reatl& complicate
va!culari*ation attempt!, with current attempt! at in vitro va!culari*ation producin" limited,
capillar&+like micro ve!!el!E '3($
In vitro va!culari*ation i! the "oal o creatin" a va!culari*ed ti!!ue, in lab, which can then
be implanted or "rated to the patient$ Ater doin" !o the "oal i! that the e.i!tin" va!culature will
ino!culate the con!truct in a timel& manner !o that the con!truct doe! not become h&po.ic$ %he
method o creatin" va!culari*ed !heet! i! accompli!hed b& !upplementin" cardioc&te !heet! or
!caold! with endothelial cell! and peric&te! '3($ While the!e pre+va!culari*ed cell !heet!
perorm better than !imple !heet!, the& !till ace the !ame i!!ue o needin" timel& ino!culation in
order to !urvive$ Ino!culation i! the proce!! b& which the artiiciall& created con!truct i! oined
into the e.i!tin" circulator& !&!tem$ /tudie! have thi! takin" up to !everal da&!, a timerame
which cau!e! i!chemic cell death '3($ Method! which have been ound to decrea!e cell death
8
-
7/25/2019 Cell Sources for Cardiac Tissue Engineering: In-vivo approach
9/21
have been to include an"io"enic actor! !uch a! VBC;, platelet+derived "rowth actor, ibrobla!t
"rowth actor, and other! to decrea!e the time it take! to ino!culate con!truct '3($ In combination
with the development o capillarie!, method! have been ound to "uide the ormation o micro
e!!el! in !uch wa&! that the& are uniorm '2($ %hi! i! a nece!!ar& criteria in the ormation o
uniorm cardiac ti!!ue$ %he primar& method! u!ed or "uidin" va!culari*ation in vitro i! the u!e
o porou! or patterned !caold! which can be !eeded with an"io"enic c&tokine! which create a
pro+an"io"enic microenvironment '2($ %hi! methodolo"& make! the creation ti"htl& controlled
con!truct! po!!ible, a! one can !ee the developin" ti!!ue create more robu!t !caold!= however, it
ace! a ke& !hortcomin" in the inabilit& to properl& ino!culate in a timel& a!hion$ Intrin!ic
va!culari*ation method! aim to combat thi!$
A! the name !u""e!t!, intrin!ic va!culari*ation approache! allow u!e the bod&F! own
an"io"ene!i!, a! current method! aim ir!t to develop a va!cular !&!tem and then add the
nece!!ar& cell!$ )urrentl&, a primar& area o re!earch in thi! methodolo"& i! the u!a"e o
arteriovenou! and low throu"h chamber!$ )onceptuall&, the!e unction b& con!tructin" a
9
Figure 1 [16]
-
7/25/2019 Cell Sources for Cardiac Tissue Engineering: In-vivo approach
10/21
va!cular pedicle, and i!olatin" it rom the !urroundin" ti!!ue u!in" a pol&carbonate chamber '3($
In thi! !cenario, new microcirculator& ve!!el! and va!culature !prout rom the i!olated
va!culature '3($ Ideall&, thi! chamber i! !upplied with !tem or pro"enitor cell!, which would then
orm the cardiac ti!!ue '23($ @e!earcher! ound however that i !tem or pro"enitor are placed in
the chamber at the be"innin" o the e.periment, then h&po.ia occur! a! would be e.pected$ %o
combat thi!, %ilkorn et al$ created a !caold which allow them to dela& the in!ertion o cell! until
the& !aw !uicient va!culari*ation o the con!truct+ around da& 7$ At thi! point, pro"enitor cell!
were inected into the !caold which had the nece!!ar& va!culature to !upport them$ %ilkorn et al
demon!trated that implanted m&obla!t !urvival in an in vivo ti!!ue en"ineerin" con!truct i!
po!itivel& correlated to the va!cularit& o the con!tructE$
10
-
7/25/2019 Cell Sources for Cardiac Tissue Engineering: In-vivo approach
11/21
:o!!ibl& the mo!t ambitiou! con!truct methodolo"& i! the decellulari*ed heart$ :ioneered
b& >tt et al, the team h&pothe!i*ed that the be!t va!culari*ation wa! provided b& nature '9($
)on!e#uentl&, the team developed a peru!tion decellulari*ation protocol$ @at heart! were
decellulari*ed u!in" a combination o three deter"ent !olution!, :BC in deioni*ed water, 15
%riton G+100 deioni*ed water, and 15 /D/ in deioni*ed water$ Ater thi! proce!!, all cellular
con!tituent! were removed, while )olla"en! I and III, laminin, and ibronectin remained intact$
Al!o, thi! method circumvent! entirel& the i!!ue o orientation and phenot&pe, a! the orientation
o the m&ocardial e.tracellular matri. wa! pre!erved$ Ater preliminar& te!tin", re!hl& i!olated
neonatal cardiac cell! and a mi.ture o other cell t&pe! were !eeded via intramural inection, and
11
-
7/25/2019 Cell Sources for Cardiac Tissue Engineering: In-vivo approach
12/21
endot
helial cell! and media were peru!ed throu"h the va!cular conduit! '9($
Figure 2 [8]
12
-
7/25/2019 Cell Sources for Cardiac Tissue Engineering: In-vivo approach
13/21
Ater ei"ht da&!, the recon!tructed or"an !howed electric and contractile re!pon!e!+ two
ke& indicator! o properl& unctionin" cardiac ti!!ue '9($ %he con!truct wa! maintained via ei"ht
dierent con!truct! or 29 da&!, and ater da& 9 mechanical te!tin" !howed that the con!truct!
could "enerate pump unction e#uivalent to 25 o an adult or 285 o a 16+week etal heart$
While thi! method i! promi!in", it !till ace! man& o the !hortcomin"! !een b& other method!$
?eneit! are that it appear! to be the mo!t promi!in" method o creatin" the nece!!ar& va!cular
!&!tem and "eometr&= however, the two maor i!!ue! it mu!t !till ace i! the procurement o cell!,
and al!o the development o mechanical unction to a de"ree that would be viable$ In the
e.periment, neonatal cardiac cell! and endothelial cell! were obtained in amount! which would
be impo!!ible to replicate currentl& in human trial! 2.107 endothelial cell! and a mi.ture o
78.106 neonatal cardiom&oc&te!,ibroc&te!, endothelial cell!, and !mooth mu!cle cell!-$ Al!o,
while the development o mechanical unction wa! notable+ ater ei"ht da&! it had the eection
capabilitie! e#uatin" to 25 o a adult heart, thi! i! a in!uicient level or tran!plantation$ ?a!ed
on the data that thi! e#uated to 16 week!, ba!ed on a linear "rowth model thi! heart would
re#uire appro.imatel& 400 da&! to reach the pump unctionalit& o a workin" adult heart$ A third
i!!ue which i! important i! lowerin" the immuno"enicit& o the !caold !o that it ma& be
po!!ible to re!eed a cadaver heart with autolo"ou! cell! to the per!on in need$
Aim ": Correlate electrical and mechanical stimulation to prior results
Blectromechanical !timulation ha! been !hown to be a maor inluence in the behavior o
developin" cardiac ti!!ue$ %here have been !everal previou! !tudie! characteri*in" the eect o
electrical and mechanical !timulation individuall&$ %he ir!t aim or thi! e.periment i! to
conirm that the procedure u!ed to culture the cardiac ti!!ue corre!pond! to the re!ult! predicted
b& the literature$ %hi! !tep i! intended to !how that the method u!ed to culture the ti!!ue i! valid
13
-
7/25/2019 Cell Sources for Cardiac Tissue Engineering: In-vivo approach
14/21
and account or di!turbance! includin" cell !ource!, !caold t&pe, and the method b& which the
cell! are !timulated$ iterature predict! that the optimal electrical !timulation will be at an
amplitude o 3 Vcm and a re#uenc& o 3 H* and that the optimal mechanical !tretch will be at
85 !tretch and 1$8 H*$ %he optimum electromechanical !timulation i! e.pected to be near the!e
value!, but ma& var& dependin" on the !peciic e.periment !etup$
%he ir!t !tep or thi! aim i! to develop a bioreactor capable o !imultaneou!l& providin"
electrical and mechanical !timulation to the "rowin" cardiac ti!!ue$ %he bioreactor will be
con!tructed b& modi&in" a method u!ed b& ;ink B%$ A$ %hi! reactor i! capable o !tretchin"
the cardiac ti!!ue up to 205 o it! ori"inal len"th u!in" !tretchin" rod! attached to the ti!!ue1$
)arbon rod electrode! will be placed len"thwi!e alon" the bioreactor to provide a con!tant
electrical ield "radient acro!! the !caold$ )are will be taken to en!ure that the movement o
the cell! i! not re!tricted and the cell! can be ob!erved throu"hout the e.periment$
Figure 3 Left- stretching apparatus. Right- carbon electrodes
>nce a unctionin" apparatu! to provide the nece!!ar& electromechanical !timulation ha!
be obtained, the optimal parameter! or the !timulation can be determined$ %he electrical and
mechanical !timulation will be individuall& inve!ti"ated and the optimal ma"nitude and
re#uenc& will be obtained or each$ ;or each e.periment a cardiom&oc&te monola&er will be
!eeded into the reactor with /kCM+2 medium and held at 37 o)$
14
-
7/25/2019 Cell Sources for Cardiac Tissue Engineering: In-vivo approach
15/21
%he electrical !timulation procedure will be de!i"ned to mimic that o %andon B% A$2
%he ti!!ue monola&er will be !ubu"ated to !#uare electrical pul!e! 24 hour! ater !eedin"$ %he
!timulation will continue or three da&! beore re!ult! are collected$ %he amplitude o the
electrical !timulation will be varied orm 1+9 Vcm and the re#uenc& will be varied rom 1+8 H*$
%he mechanical !timulation procedure will be ba!ed o o the method! u!ed b& ;ink B% A$ to
implement mechanical !tretch$ nidirectional !tretch will be applied to the ti!!ue our da&! ater
the cell! were !eeded in the !caold$ %he !tretchin" will continue or !i. da&! and then the
re!ult! will be collected$ %he !tretch amplitude will be varied rom 15 to 205 o the len"th o
the ti!!ue and the re#uenc& varied rom 1+8 H*$
B.citation thre!hold, ma.imum capture rate, amplitude o contraction, and hi!tolo"& will
be u!ed a! metric! to determine the optimum !timulation or the ti!!ue monola&er!$ %he
e.citation thre!hold i! a mea!urement o the ti!!ueF! electrical e.citabilit&, and i! determined b&
the minimum amplitude re#uired to cau!e the ti!!ue to beat at 60 beat! per minute$ A low
e.citation thre!hold value i! preerred or optimal cardiac ti!!ue$ %he ma.imum capture rate i!
the re#uenc& that the ti!!ue will contract when e.po!ed to electrical pul!e! with an amplitude
1$8 time! the e.citation thre!hold$ A hi"h capture rate value indicate! !tron" intercellular
connectivit& and i! de!ired or cardiac ti!!ue$ %he amplitude o contraction i! mea!ured in
percent chan"e in the ti!!ueF! !urace area durin" a contraction$ A lar"e amplitude o contraction
indicate! more unctional cardiac ti!!ue$ %he hi!tolo"& o the cultured ti!!ue will be compared to
that o natural ti!!ue$ %he hi!tolo"& will be u!ed to "ive a #ualitative anal&!i! o the optimum
ti!!ue$
15
-
7/25/2019 Cell Sources for Cardiac Tissue Engineering: In-vivo approach
16/21
16
-
7/25/2019 Cell Sources for Cardiac Tissue Engineering: In-vivo approach
17/21
Aim #: Com$ine electrical and mechanical stimulation
Ater aim 1 ha! !hown the validit& o the !timulation procedure, the eect o combinin"
the electrical and mechanical !timulation will be inve!ti"ated$ %he cell! will be !eeded in the
reactor, ollowin" the !ame procedure a! in aim 1$ Ater the cell! are cultured or 24 hour! the
ti!!ue will be e.po!ed to electrical !timulation or three da&!$ ;our da&! ater the cell! were
!eeded= unidirectional mechanical !tretch !timulation will be applied in addition to the electrical
!timulation$ %he cell! will be let in the culture or a total o 10 da&! beore the& are lited and
mea!urement! are taken$ %he !ame metric! u!ed in aim 1 will be u!ed to determine the optimum
!timulation or cardiac ti!!ue!$ %he re!ult! o aim 2 will provide novel inormation re"ardin" the
eect that multiple t&pe! o !timulation ha! on cardiac ti!!ue$
Aim %: Increasing Construct Thic&ness and Angiogenesis
Havin" created electromechanicall& optimi*ed cell !heet! via aim! one J two, the "oal o
aim three i! to a create a thicker cell con!ruct b& !tackin" !heet! o cardiom&oc&te!+ with
17
-
7/25/2019 Cell Sources for Cardiac Tissue Engineering: In-vivo approach
18/21
!par!el& cultured aortic endothelial cell !heet! placed in between to promote an"io"ene!i!$
Without an& an"io"ene!i! promoter!, a! noted earlier the limit o con!truct thickne!! wa!
appro.imatel& 3 cell! thick$ /chimi*u et alreco"ni*ed the need or va!culari*ation in the!e
con!truct! and be"an e.perimentin" with the u!e o endothelial cell la&er!, with which he wa!
able to create a 8 la&er thick con!truct$ ?uildin" o o thi!, we de!ire to re!earch whether a
!i"niicant increa!e in value i! ound b& perormin" thi! e.periment with electromechanicall&
!timulated cell!$ We will con!ider thi! aim a !ucce!! "ranted we !ee hi"her ma.imum capture
rate, contraction amplitude, and e.citation thre!hold than the control model!$ >ur control model!
will be dierntiated b& lackin" electrochemical optimi*ation$
%he novel method de!i"ned b& /chimi*u relied upon two dierent, temperature
dependent material! ibrino"en "el, which ha! a meltin" point at 37K) and a adherin"
temperature o 20K), and :ol& +i!oproplacr&lamide- which ha! a relea!e temp o 20K) and and
adehe!ion temperature o 32+ 37K)$ Due to the nature o the!e material!, it i! po!!ible to create
lit cell !heet! and !tack them in a or"ani*ed manner$ An overview o the method i! !een in i"ure
GGG$
Aim 4 Animal Model
%hrou"h the indin"! and re!ult! o the previou!
aim!, it i! nece!!ar& to demon!trate the clinical potential u!in" non+
human model!$ :reviou! work ha! !hown promi!e in re"ard! to !howin"
!u!tained development o the tran!planted la&er!$ %alk about previou! workE
18
-
7/25/2019 Cell Sources for Cardiac Tissue Engineering: In-vivo approach
19/21
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
ikewi!e or a pre!ent model, demon!tratin" the abilit& o the optimi*ed cell la&er! to re"enerate
heart unction would be the ultimate "oal$
!aterials and !ethods
Animals
%he !tud& will emplo& u!in" a !mall+animal model con!i!tin" o adult male ewi! rat! around
12+14 week! old$ %he ewi! rat !train i! the mo!t common !train ound within the ti!!ue
en"ineerin" ield and i! readil& available or purcha!e$ cite :h&!iolo"icall&, the rat model will
e.hibit health& condition! !uch a! wei"hin" around 380 "ram! and recordin" a heart rate o
around 400 per minute$ L o animal! needed or "roupin":ower anal&!i!
All animal te!tin" will be conducted in compliance with the Animal Welare Act and the Cuide
or the )are and !e o aborator& Animal!$
Artificial Infarction Procedure
In order to produce an inarction event within the animal model, the u!e o an eicient and
!u!tained procedure i! re#uired$ Man& method! o inducin" an inarction contain hi"h mortalit&
rate! and have let !ome !ubect! unable or te!tin"$ >ne !uch method that i! commonl& u!ed
with improved mortalit& rate i! the li"ation o the let coronar& de!cendin" arter&$
%he !ur"er& i! perormed under "eneral ane!the!ia in which the animal! will under"o intubation$
A thoracothom& i! perormed on the let !ide o the animal, b& cuttin" the ith and !i.th rib!$
%he thoracic cavit& will be arran"ed to be able avoid inur& to the heart$ %he !ur"eon will appl& a
!mall blade an open the pericardial membrane allowin" or a cardiac holder to be placed$$ %he
19
-
7/25/2019 Cell Sources for Cardiac Tissue Engineering: In-vivo approach
20/21
AD will be locali*ed 1N2 mm below the unction o the pulmonar& conu! and the let atrial
appenda"e ;i"$ 2and ;i"$ 3-$
%he let atrial appenda"e and the pulmonar& conu! can be identiied b& their appearance and
location above the let ventricle$ %he li"ation will occur u!in" a !uture with a curve needle$
Durin" the in!ertion o the needle, the operator !hould be careul to avoid puncture o the let
atrial appenda"e or the pulmonar& conu!, which can cau!e ma!!ive hemorrha"e$ Ater li"ation
the heart will be returned back to the thoracic cavit& and the che!t will be clo!ed$ :o!toperative
care will be continued u!in" anal"e!ia and hemod&namic monitorin" until e.tubation and ull
recover& rom ane!the!ia$
Transplantation and Post 'P Analysis
%ran!plantation o the abricated cell la&er! will occur ater !ubect! are ull& recovered$ %he
procedure o tran!plantation i! !imilar to previou! work! and will e.pect to produce the !ame
re!ult! in term! o mortalit& rate$
20
http://www.sciencedirect.com/science/article/pii/S1553838905000928#fig2http://www.sciencedirect.com/science/article/pii/S1553838905000928#fig2http://www.sciencedirect.com/science/article/pii/S1553838905000928#fig3http://www.sciencedirect.com/science/article/pii/S1553838905000928#fig3http://www.sciencedirect.com/science/article/pii/S1553838905000928#fig2 -
7/25/2019 Cell Sources for Cardiac Tissue Engineering: In-vivo approach
21/21
Ater the po!t+inarctedtran!plant !ubect! recover, the e.tent o m&ocardial dama"e or recover&
will need to be #uantiied$ %hrou"h the non+inva!ive and applicabilit& to !mall animal model, the
u!e o B)C or Blectrocardio"raph& will be implemented in order to determine the dama"e$
B)CF! !peciicall& mea!ure the !tren"th and timin" o electrical !i"nal! in the heart$ ;rom the!e
mea!urement! the eection raction o the heart can be ound$ ;urther anal&!i! mu!t be
(uture )or&
)on!tant D) electric ield
Mechanical pre!!ure !timulation
Amplitude J re#uenc& o !timuli chan"in" over time
/tackin" thicker cell la&er!
Conclusion
21